intellectual property.htm

Inflabloc has a worldwide exclusive license from the University of Utah Research Foundation to commercialize its technology and an extensive intellectual property portfolio consisting of issued and pending U.S. and foreign patents, proprietary formulations and screening assays. Patents issued to date in the U.S. are listed in the tables below:

Inflabloc Pharmaceuticals currently has a provisional patent on co-administration of DHEA cogeners and other active agents for treating inflammation.

Inflammation
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US Patent Number 5,532,230 5,489,581 5,583,126 5,587,369 5,635,496 5,686,438 5,753,640 5,811,418 5,846,963 5,977,095 6,150,348 6,187,767	Date of Patent Feb 6, 1996 Jul 2, 1996 Dec 10, 1996 Dec 24, 1996 Jun 3, 1997 Nov 11, 1997 May 19, 1998 Sep 22, 1998 Dec 8, 1998 Nov 2, 1999 Nov 21, 2000 Feb 13, 2001
Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
US Patent Number 5,922,701 5,929,060	Date of Patent Jul 13, 1999 Jul 27, 1999
Method for reducing mast cell mediated allergic reactions
US Patent Number 5,859,000	Date of Patent Jan 12, 1999

Immunology
Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S)
US Patent Number 5,919,465	Date of Patent Jul 6, 1999
Vaccine compositions and method for enhancing an immune response
US Patent Number 5,562,910 5,837,269	Date of Patent Oct 8, 1996 Nov 17, 1998
Method for enhancement of production of lymphokines and applications thereof
US Patent Number 5,540,919 5,827,841	Date of Patent Jul 30, 1996 Oct 27, 1998
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
US Patent Number 5,518,725 5,824,313	Date of Patent May 21, 1996 Oct 20, 1998
DNA construct for immunization
US Patent Number 5,795,872	Date of Patent Aug 18, 1998
Method for augmenting immunological responses
US Patent Number 5,753,237	Date of Patent May 19, 1998